Author response to: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.
作者信息
Rahman Saqib A, Underwood Timothy J
机构信息
School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK.
出版信息
Br J Surg. 2022 Jul 15;109(8):e92. doi: 10.1093/bjs/znac130.
Abstract
摘要
相似文献
1
Author response to: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.作者对以下内容的回应：术前化疗和手术后，术后化疗对食管胃腺癌生存的影响。
Br J Surg. 2022 Jul 15;109(8):e92. doi: 10.1093/bjs/znac130.
2
Comment on: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.评论：术前化疗及手术后，术后化疗对食管胃腺癌生存情况的影响
Br J Surg. 2022 Jul 15;109(8):e91. doi: 10.1093/bjs/znac129.
3
Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.术前化疗和手术治疗后，术后化疗对胃食管腺癌生存的影响。
Br J Surg. 2022 Feb 1;109(2):227-236. doi: 10.1093/bjs/znab427.
4
Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?支持可手术胃癌围手术期化疗的一级证据：是否足以广泛应用于临床？
Ann Surg Oncol. 2007 Oct;14(10):2691-5. doi: 10.1245/s10434-007-9358-z. Epub 2007 Jul 26.
5
Safety, efficacy, and long-term follow-up evaluation of perioperative epirubicin, Cisplatin, and capecitabine chemotherapy in esophageal resection for adenocarcinoma.围手术期表柔比星、顺铂和卡培他滨化疗在食管癌腺癌切除术中的安全性、疗效及长期随访评估
Ann Surg Oncol. 2015 May;22(5):1555-63. doi: 10.1245/s10434-014-4120-9. Epub 2015 Jan 7.
6
[A Case of Advanced Adenocarcinoma at the Esophagogastric Junction That Exhibited pCR by Preoperative SOX Therapy].[1例经术前SOX治疗达到病理完全缓解的食管胃交界部晚期腺癌]
Gan To Kagaku Ryoho. 2022 Jun;49(6):693-696.
7
Gastro-oesophageal junction: to FLOT or to CROSS?胃食管交界部：选择FLOT方案还是CROSS方案？
Acta Oncol. 2020 Feb;59(2):233-236. doi: 10.1080/0284186X.2019.1698765. Epub 2019 Dec 9.
8
Perioperative Chemotherapy in Elderly Patients with Locally Advanced Adenocarcinoma of the Stomach and the Esophagogastric Junction: A Retrospective Cohort Analysis of Toxicity and Efficacy at the National Center for Tumor Diseases, Heidelberg.老年局部晚期胃癌和食管胃交界腺癌患者的围手术期化疗：海德堡国家肿瘤疾病中心毒性和疗效的回顾性队列分析
Oncology. 2017;92(5):291-298. doi: 10.1159/000458531. Epub 2017 Mar 2.
9
A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study).一项针对HER2阳性伴广泛淋巴结转移的晚期胃癌或食管胃交界腺癌患者，对比单纯全身化疗与联合曲妥珠单抗全身化疗后行手术治疗的随机II期试验：日本临床肿瘤学会研究JCOG1301（触发研究）
Jpn J Clin Oncol. 2015 Nov;45(11):1082-6. doi: 10.1093/jjco/hyv134. Epub 2015 Sep 9.
10
Controversies and Consensus in Preoperative Therapy of Esophageal and Gastroesophageal Junction Cancers.食管癌和食管胃交界癌术前治疗的争议与共识
Surg Oncol Clin N Am. 2017 Apr;26(2):241-256. doi: 10.1016/j.soc.2016.10.009. Epub 2017 Feb 9.
本文引用的文献
1
Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery.术前化疗和手术治疗后，术后化疗对胃食管腺癌生存的影响。
Br J Surg. 2022 Feb 1;109(2):227-236. doi: 10.1093/bjs/znab427.
Zotero 插件